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Background
Literature has focused on effect sizes rather than individual-level
improvement rates to determine how effectively services
address burgeoning numbers of adolescents with anxiety and
depression.
Aims
To consider how many adolescents report reliable improvement
in anxiety, depression and comorbid depression and anxiety by
end of treatment.
Method
The primary outcome was reliable improvement (i.e. change
greater than likely the result of measurement error) in self-
reported anxiety and depression for N = 4464 adolescents (mean
age 14.5 years, s.d. = 1.9; 75% female; 61% White) seen in spe-
cialist mental health services in England.
Results
In total, 53% of those with anxiety, 44%with depression, and 35%
with comorbid depression and anxiety showed reliable
improvement.
Conclusions
Improvement rates were higher than previously reported, but
lower than generally used in advice to the public. Theremay be a
need to set more realistic expectations, including with young
people who seek help.
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There is evidence of increasing levels of anxiety and depression in
adolescents internationally,1–7 leading to an emphasis on the need
for more treatment access. However, there is much less discussion
or evidence about howmany are substantially better following treat-
ment nor how to discuss the limitations of treatment outcomes. The
dominant message currently is to encourage children to seek treat-
ment and to emphasise the likely positive outcomes from treatment.
The most respected current guidance offers no reference to likely
improvement rates for those accessing therapy for anxiety and/or
depression. For example, in the UK, in the National Institute for
Health and Care Excellence public recommendations on treatment
for anxiety and depression in children and young people, there is no
mention of improvement rates and no quality standards in relation
to improvement expected to be achieved following access to ser-
vices.8,9 Nor is any mention of this made in guidance from the
Royal College of Psychiatrists.10 Websites offering information to
the public stress the need for help and suggest that without help chil-
dren and adolescents will not improve, but with help they will. For
example, according to the website of the Anxiety and Depression
Association of America: ‘Like other medical conditions, anxiety dis-
orders tend to be chronic unless properly treated. Most kids find
that they need professional guidance to successfully manage and
overcome their anxiety’.11
Outcomes of treatment are generally reported in terms of effect
size differences between treatments12 or between before and after
treatment, and not in terms of individual-level improvement
rates. Recently, use of effect sizes has been critiqued as potentially
contributing to overinflated estimates of impact for a given individ-
ual as it does not include any consideration of clinically meaningful
metrics of change, nor does it take into account differences between
individuals in terms of outcomes, and that focusing on mean
differences can be misleading in terms of the likely impact on indi-
viduals. This may be true in a number of ways; for example, if a
small number of people improve a lot and a large number of
people improve a little (or even some get worse), the mean result
may look positive. Alternatively, everyone could improve but by
such small amounts as to be not meaningful in relation to their
daily lives. Thus, looking at effect size as a metric might not be the
most useful statistic and, in particular, may not be of help to people
providing or receiving treatment.13 There has therefore been a call
for a focus on metrics of outcome that focus on individual responses
to treatment that may be more clinically relevant and meaningful.14
The metric of ‘reliable change’ is increasingly being suggested
for use15–18 as an estimate of potentially clinically important
change at the individual level. Reliable change refers to the
amount of change in scores on a scale; it ‘tells us whether change
reflects more than the fluctuations of an imprecise measuring
instrument’.19 This metric considers whether improvement (or
indeed deterioration) in symptoms is greater than could likely be
solely attributed to measurement error.
The systematic review of child mental health research con-
ducted for this article found only five studies that examined self-
reported reliable improvement following exposure to routine care* These authors are joint first authors.
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for young people with anxiety and/or depression. These have all
been undertaken in the USA, Australia or Scandinavia and
employed small samples (n = 11–85 adolescents) and report low
rates of reliable improvement (8–36%) with 0–10% deterioration
(see Table 4).
There is thus an important gap in the literature about individ-
ual-level rates of improvement following care. This is crucial infor-
mation to help practitioners set realistic expectations for outcomes
and support adolescents to make informed choices about their care.
The aim of the present research was to address this gap by consider-
ing howmany adolescents’ reports indicate reliable improvement in
anxiety, depression and comorbid depression and anxiety by end of
treatment.
Method
Participants and procedure
Data were collected from 75 services where practitioners were
trained in key evidence-based interventions and use of feedback
and outcome monitoring (Children and Young People’s
Improving Access to Psychological Therapies (2011–2015)20).
Services were part of publicly funded provision and staffed by
multidisciplinary teams including nurses, psychologists, psychia-
trists, counsellors and others. The programme emphasised provi-
sion of evidence-based interventions for given problems such as
cognitive–behavioural therapy for anxiety and depression or inter-
personal therapy for depression but the majority of treatment pro-
vided drew on a range of interventions.
The treatment episodes’ participants were deemed eligible for
analysis if they were recorded as ‘closed’ and had at least three
recorded events (at least one of which was for a purpose other
than assessment), n = 27 439; the participants had completed a
self-reported measure of anxiety or depression (see Measures)
at assessment, n = 13 885; was between the age of 8 and 18, n =
13 599; and scored above the threshold at assessment for their
school year and gender on either the anxiety (i.e. social phobia,
separation anxiety, panic disorder, or generalised anxiety) or
depression subscales, n = 9028 episodes of care. Of these, 8927
were unique individuals and 101 were re-referrals of the same indi-
vidual in this period.
Note that it was not possible to be certain that the last available
record was at the same time point as end of treatment but we can be
sure it was the last recorded measure by end of treatment and that it
was further to the first recorded measure.
Data were then filtered to include only those episodes of treat-
ment where the same measure of anxiety or depression completed
at assessment was also completed on more than one occasion in
the same episode of treatment (referred to as ‘paired’ data). Scores
from the first-ever and last-ever recorded completion of the mea-
sures were then analysed to assess change in self-reported anxiety
and depression symptoms over time. This resulted in a final
included sample of n = 4464 episodes of care (49.4% of the time
1 total sample, from 70 services).
Demographic characteristics for the total and final samples are
presented in Table 1. There were some significant differences in age,
gender and ethnicity between those episodes of treatment from the
final sample and the total sample but no differences in Revised Child
Anxiety and Depression Scale (RCADS)21 scores. All differences
found displayed small effect sizes. Young people in the final
sample were slightly older compared with those in the total
sample (odds ratio (OR) = 1.2, 95% CI 1.1–1.3), slightly more
likely to be female (OR = 1.2, 95% CI 1.1–1.3), slightly less likely
to be of mixed ethnicity (OR = 0.7, 95% CI 0.5–0.9), and slightly
more likely to have not stated their ethnicity (OR = 1.2, 95% CI
1.1–1.4). As measures were taken from a secondary analysis of
anonymised routinely collected data, ethical review was not
required.22
Measures
Demographic characteristics
Age, gender and ethnicity were recorded by services as part of
routine data recording. Ethnicity was captured based on self-
report by the carer or adolescent and were grouped as follows:
White (including White British, Irish, and other White back-
ground), mixed (including mixed White and Black Caribbean,
mixed White and Black African, mixed White and Asian, and any
other mixed background), Asian or Asian British (including
Indian, Pakistani, Bangladeshi and other), Black or Black British
(including Caribbean, African and other) and other ethnic groups
(including Chinese and other).
Table 1 Descriptive characteristics of episodes of care with data at assessment only compared with those with ‘paired’ data
Data at assessment Paired data Odds ratioa (95% CI)
n Mean (s.d.) % n Mean (s.d.) %
Age, years 4564 14.3 (2.2) 4464 14.5 (1.9) 1.2 (1.1–1.3)
Gender
Male 1300 28.5 1120 25.1 1.2 (1.1–1.3)
Female 3264 71.5 3344 74.9
Ethnicity
White 2885 63.2 2721 61.0 0.9 (0.8–1.0)
Black 132 2.9 97 2.2 0.8 (0.6–1.0)
Mixed 163 3.6 111 2.5 0.7 (0.5–0.9)
Asian 96 2.1 87 1.9 1.0 (0.7–1.2)
Other 75 1.6 81 1.8 1.1 (0.8–1.5)
Not stated 883 19.3 1008 22.6 1.2 (1.1–1.4)
Missing 330 7.2 359 8.0 1.1 (1.0–1.3)
Baseline RCADS t-scores
Separation anxiety 4389 70.4 (17.1) 4177 71.3 (16.3) 1.1 (1.0–1.2)
Social phobia 4380 60.2 (12.1) 4187 61.4 (11.8) 1.2 (1.1–1.3)
Panic 4362 72.0 (17.5) 4172 73.6 (17.5) 1.2 (1.1–1.3)
Generalised anxiety 4423 59.9 (11.6) 4186 60.7 (11.1) 1.1 (1.0–1.2)
Depression 4432 74.5 (14.3) 4296 75.0 (14.3) 1.1 (1.0–1.1)
RCADS, Revised Child Anxiety and Depression Scale.
a. Log odds ratios for continuous variables were calculated using Cohen’s d based on independent sample t-tests, using the formula log(o) = (pi d)/(sqrt(3)).
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Anxiety and depression
To measure the presence and severity of anxiety and depressive
symptoms, the 47-item RCADS21 was used. The RCADS measures
symptoms of anxiety and depression and is composed of six sub-
scales (depression, social phobia, separation anxiety, generalised
anxiety, panic disorder and obsessive–compulsive disorder). Items
are rated on a four-point scale from 0 (never) to 3 (always). In add-
ition to the full 47-item questionnaire, the individual subscales were
also used as shorter, stand-alone measures. The subscale for obses-
sive–compulsive disorder was excluded from this analysis as the lit-
erature suggests that the aetiology and course of this disorder may
be different from the other four anxiety disorders measured by
the RCADS.23
The RCADS is a widely used measure of child anxiety and
depression, with evidence of validity and reliability (Cronbach’s
α = 0.78–0.88 across the six subscales).21 According to data collec-
tion protocol, the full RCADS should be completed at initial assess-
ment, then again 4–6 months later, or at case closure if sooner. The
subscales of the RCADS may be used as stand-alone measures more
frequently, and at the discretion of the practitioner, in order to track
progress on specific symptoms throughout the episode of care.24
The RCADS was found to be sensitive enough to pick up a
change in anxiety and depression symptoms experienced by chil-
dren and adolescents up to 12 months after receiving a preventative
intervention.25 Thresholds were based on norms from a study of
school children in the USA.22 In line with recommendations in
the RCADS user guide, children were considered above the thresh-
old if they had a t-score of 65 or greater for children of their school
year and gender, indicating a score in the top 6% of the sample.26
Analytic strategy
First, we examined the primary outcome of whether change in
scores was greater than could likely be solely attributed to measure-
ment error by calculating the reliable change criterion.19 A reliable
change criterion was calculated for each subscale of the RCADS as
shown in the formulae below, using the internal consistency of the
subscale and the s.d. of the final included sample at the first time
point.
Reliable change criterion ¼ SEdiff × 1:96; where
SEdiff ¼ s:d: × √2 ×
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 reliability
p
For those scoring above the threshold at assessment, participants
that exhibited improvement in scores greater than the reliable
change criterion were deemed ‘reliably improved’, participants
with deterioration in scores greater than the reliable change criter-
ion were deemed ‘reliably deteriorated’, and individuals not crossing
the reliable change criterion were categorised as showing ‘no reliable
change’. To avoid multiple classification of participants when
analysing anxiety individually and when analysing comorbid
depression – where one patient could have both reliably improved
and reliably deteriorated (or not reliably changed) on different
subscales – the individual was considered reliably improved if
they showed reliable improvement on at least one elevated subscale
and no reliable deterioration on any of the other subscales.
Conversely, a patient’s condition was classified as reliably deterio-
rated if they had reliably deteriorated on any subscale. For partici-
pants with comorbid depression and anxiety, both elevated scales
had to show reliable improvement for the individual to be classified
as reliably improved.
Secondary analysis considered whether scores crossed to below
cut-off at follow-up (i.e. ‘recovered’) or remained above the cut-off
at follow-up (i.e. ‘non-recovered’). To avoid multiple classification
of participants when analysing anxiety individually and when ana-
lysing comorbid depression and anxiety – where one patient could
be both recovered and non-recovered on different subscales – a
patient needed to be above the threshold on one subscale at assess-
ment but below the threshold on all subscales at follow-up for their
condition to be classified as recovered.
A further secondary analysis used the most conservative
approach to examining change by assessing ‘reliable recovery’.
Here, participants that crossed from above the thresholds at assess-
ment to below at follow-up and which demonstrated an improve-
ment in score greater than the reliable change threshold on the
same subscale (i.e. reliably improved) were classified as ‘reliably
recovered’.
We performed logistic regressions to examine whether demo-
graphic characteristics were associated with reliable improvement,
recovery and reliable recovery. Most demographic characteristics
did not significantly predict treatment outcome; however, gender
was a significant predictor of recovery for the anxiety and depres-
sion comorbid group, although the regression model was only
able to explain 1% of the variance in recovery (see Supplementary
Tables 1–3, available at https://doi.org/10.1192/bjo.2018.31).
In addition, pre–post effect size calculations were carried out for
each subscale based on the sample of participants who were above
the threshold for each scale. It should therefore be noted that the
sample used to calculate these effect sizes were not the same as
the samples used for themain analyses. These effect size calculations
were included for the sole purpose of aiding discussion of how indi-
vidual-level metrics might be considered alongside results from
effect size metrics. Effect sizes were calculated as (MeanTime 1 –
MeanTime 2)/s.d.Time 1. The CIs were estimated with the R package
‘boot’27 using 10 000 bootstrap samples.
Results
The results of the analyses are shown in Tables 2 and 3.
Anxiety
From the final sample of n = 4464 participants, 1208 were above the
threshold on at least one of the anxiety subscales at assessment and
not above the threshold for depression. The reliable change indices
in t-scores were 12.26 for generalised anxiety, 16.78 for panic dis-
order, 21.17 for separation anxiety, and 11.75 for social phobia.
Table 2 Reliable change, recovery and reliable recovery in anxiety,
depression and comorbid samples
Anxiety
n = 1208
Depression
n = 621
Comorbid
depression
and anxiety
n = 2635
n % n % n %
Reliable change
Reliable improvement 638 52.8 275 44.3 913 34.6
No reliable change 400 33.1 323 52.0 751 28.5
Reliable deterioration 93 7.7 23 3.7 256 9.7
Recovery
Recovered 736 60.9 350 56.4 1020 38.7
Non-recovered 472 39.1 271 43.6 1615 61.3
Reliable recovery
Recovered 555 45.9 258 41.5 672 25.5
Non-recovered 653 54.1 363 58.5 1963 74.5
a. Participants were considered to be above the threshold if they had a t-score of 65 or
greater for their school year and gender, based on developers’ norms.
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Depression
From the final sample of n = 4464 participants, 621 were above the
threshold for depression and not above the threshold for any anxiety
problems at assessment. The reliable change criterion for depression
was 14.29, meaning individuals with t-scores that changed by more
than 14.29 points were classified as having reliably changed.
Comorbid depression and anxiety
From the final sample of n = 4464 participants, 2635 were above the
threshold for the depression subscale and at least one anxiety sub-
scale at assessment. Of participants above cut-off for the depression
subscale and at least one anxiety subscale at assessment, 913 (i.e.
34.6%): (a) reliably improved on the depression subscale, (b) reliably
improved on at least one anxiety subscale that was above the thresh-
old at assessment, and (c) had not reliably deteriorated on any
subscale.
Pre–post effect sizes
Pre–post effect sizes for each subscale were calculated, drawing in
each instance on the sample of children who were above the thresh-
old at outset for that subscale. These are shown in Table 3.
As can be seen, pre–post effect sizes ranged from 0.8 (for
separation anxiety, 95% CI 0.8–0.9) to 1.4 (for generalised anxiety,
95% CI 1.3–1.4). These would be deemed ‘large’ effect sizes.28
Discussion
Main findings
In the present research, 53% of young people with anxiety and no
comorbid depression reliably improved, 44% with depression and
no comorbid anxiety reliably improved and 35% with comorbid
depression and anxiety reliably improved. The difference between
anxiety, depression and comorbid depression and anxiety were in
line with earlier findings, although the overall rates of reliable
improvement were somewhat higher than in the five previous
studies identified in our systematic review (see Table 4).
Interpretation of our findings
These rates of individual improvement are in contrast with how the
results might have been conceived if this paper had focused on pre–
post effect size analyses. These effect sizes, which ranged from 0.8 to
1.4, could have been deemed large effect sizes drawing on rules of
thumb as described by Cohen.28 Although many (including the
current authors) would argue that such a designation would be
inappropriate since these rules of thumb do not apply to pre–post
measurements because of the non-independence of the data, and
the fact that the s.d. chosen to calculate the effect size often
results in changes of over 0.4 in the effect size itself,34 in practice
these rules are extensively applied also for pre–post effect sizes
(for example Edlund et al29). The lack of rules of thumb for mean-
ingful use of effect sizes pre–post adds to the challenges of using
such statistics where no benchmarks exist.
It is important to note that these outcomes only appear modest
when considered relative to the expectations that are being engen-
dered by public-facing discourse and a lack of professional discus-
sion of the fact that child mental health treatment will not help
everyone (as noted above). In fact, these sort of rates of reliable
improvement are closely in line with reliable improvement rates
found in other psychological therapy for adults15 and are higher
than the modest extant literature of comparable studies on psycho-
logical therapy for adolescents and higher than many physical
health outcomes for conditions that may be seen as chronic, such
as paediatric diabetes where positive recorded outcome rates
(based on control of haemoglobin A1c to under a threshold of 7.5)
have risen from around 15% in 2009–10 to around 24% in 2014–
15.35 One of the implications of this approach is that it might
form the basis for more considered discussions around realistic
expectations for treatment.
Limitations
There are clearly limitations to this research.20,36 Only 49% of the
adolescents with self-report measures at assessment had data at
case closure so this analysis is based on a sample with much
missing data. It is highly likely that there will be skews in the data
in terms of who completed the questionnaires at both time points
even though it should be noted that there were not differences
found in the level of symptoms on RCADS scores between
samples at outset, suggesting that this at least was not a source of
skewing the data. We know from the sample analysis that adoles-
cents who completed self-reported measure at both time points
were generally somewhat older and less ethnically diverse than
those who completed any child- or parent-reported assessment.20
The question is whether this might have substantially affected the
improvement rates. For example, it could be that those with the
most improvement ended therapy early and did not complete a
measure at a second time point, thus decreasing the overall
improvement rates. Alternatively, it could be that those who
achieved most in therapy were most motivated to complete the
Table 3 Pre–post effect sizes and 95% CIs of the Revised Child Anxiety
and Depression Scale (RCADS) subscalesa
RCADS subscales n Pre–post effect size (95% CI)
Social phobia 1500 1.0 (1.0–1.1)
Separation anxiety 2081 0.8 (0.8–0.9)
Panic 2229 0.9 (0.9–1.0)
Generalised anxiety 1149 1.4 (1.3–1.4)
Depression 3052 0.9 (0.9–0.9)
a. The sample sizes reflect the number of closed episodes of care with a score above the
subscale threshold at a first time point.
Table 4 Reliable improvement and deterioration in anxiety, depression and comorbid anxiety and depression from the present research and previous
studies
Anxiety, % (n/N) Depression, % (n/N)
Comorbid anxiety and
depression or mixed
emotional problems, %
(n/N)
This study
Edlund
et al
(2016)29
Jónsson
et al
(2015)30
Biegel
et al
(2009)31 This study
Hayes
et al
(2011)32
Edlund
et al
(2016)29
Biegel
et al
(2009)31 This study
Nilsen et al
(2015)33
Reliable improvement 53 (638/1208) 36 (19/53) 28 (24/85) 20 (8/40) 44 (275/621) 36 (4/11) 27 (14/51) 28 (11/40) 35 (913/2635) 8 (1/13)
Reliable deterioration 8 (93/1208) 8 (4/53) 6 (5/85) 3 (1/40) 4 (23/621) 0 (0/11) 10 (5/51) 10 (4/40) 10 (256/2635) 0 (0/13)
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measures and their impact resulted in inflating the improvement
rates in the final sample. Additionally, because of a lack of data
on income and deprivation we were unable to assess the potential
impact of these factors on outcomes. Only further studies with
more complete datasets will be able to address these questions
empirically. However, findings from other studies with reduced
questionnaire response rates would suggest that, generally, the
latter hypothesis holds; i.e. the sample is likely to be skewed to
those who feel more positive about their treatment.37
The focus on case closure as the only follow-up time point for
assessing the impact is also a limitation. There is an increasing inter-
est in the longer-term outcome of therapy and it may be that an
impact does not show itself until some years later, as a ‘sleeper’
effect.38 However, even if this were the case it would be important
to know what the likely outcome is at case closure to support
informed expectations around this.
The fact that the research focused on adolescent self-report alone
may also be a limitation. It is known that there are significant differ-
ences between adolescents, their parents and those seeking to treat
them in terms of their perspectives on the nature and the progress
of the problem. We chose to focus on adolescent self-report as this
viewpoint has been more overlooked in previous research and the
experience of the person is clearly crucial. However, future research
could also focus on practitioner, parent and teacher perspectives.
The fact that no UK norms existed for the measure used is a
limitation and could mean that adolescents completed the question-
naires in different ways that may have skewed the data. However,
the fact that change in scores was being considered should minimise
the impact of this issue to some extent. A further limitation is the
focus on reliable change in symptoms as the key metric of
outcome. This can be critiqued from two perspectives. First, the
concept of reliable change itself is only from a statistical point of
view. It relates to the amount of change in scores that makes it
unlikely to be because of measurement error alone. But this does
not mean it is a significant change from the perspective of the indi-
vidual, nor might it be reliable in the lay sense of being relied upon
to be maintained over time. Moreover, solely focusing on symptoms
could be criticised. A more holistic approach focusing on change in
othermetrics may bemore important to the adolescent’s life, such as
functioning in school, ability to manage their own difficulties or
interpersonal relationships. Both these limitations could be
addressed by developing further refined metrics and approaches,
ideally coproduced with young people themselves, and are issues
we are exploring further. However, in the meantime, reliable
improvement on symptom change could be argued to be the best
and most transparent measure.
Implications
Notwithstanding the limitations, the findings raise important im-
plications for research and practice in relation to meeting the
needs of young people with anxiety and depression. Greater explor-
ation of this area with more complete data-sets, refined metrics and
multiple perspectives is needed. Future research could look at com-
binations of outcomes as proxy for recovery and it will be important
to consider qualitative findings to explore further the experience of
both recovery and non-recovery in treatment. While this research is
being developed and the evidence base extended, there are some
potential implications for practice that are considered below.
One key implication for practice is the need for a recalibration of
what is said to young people and the wider public about the likely
immediate measurable outcome of therapy to rebalance the focus
on the possibility of therapy helping with a realistic appropriate
appraisal of the fact that not everyone will be measurably improved
by the end of treatment.
These findings need to be considered in the context of research
into spontaneous remission among adolescents for depression and
anxiety. Whiteford et al’s ground-breaking review39 of spontaneous
remission in depression found that children and adolescents were
more likely to achieve remission without treatment than adults,
and achieve it faster, and that spontaneous rates of remission for
young people could range up to 48%. In Weisz et al’s seminal
meta-analysis12 they note the ‘probability that a randomly selected
youth in the treatment condition would be better off after treatment
than a randomly selected youth in the control condition [which was
generally a wait list control] was 63% – only moderately better than
chance at 50%’.
These, combined with the current findings and other
research,29–33 thus present an increasingly substantial challenge to
the current silence on likely measurable change achieved by the
time of case closure. Some practical suggestions from the current
findings include: those developing guidance publish metrics on
reliable improvement rates – and other metrics of outcome as rele-
vant – in their recommendations to the public; service providers
setting realistic outcomes with funders (whether insurance compan-
ies or public funders) around likely improvement rates for this
population and practitioners considering what they say to children,
young people and families accessing their services in terms of likely
outcome of an episode of care.40 Clearly this needs to be balanced
carefully with the need to instil hope that has been identified as a
powerful moderator in therapeutic impact.41 However, the
current findings would suggest that more open conversations
about likely reliable improvement rates are necessary, and poten-
tially more focus from the start as to how treatment might
enhance adolescent ability to manage ongoing symptoms and diffi-
culties that are still likely to be present at the close of treatment.
There may even be therapeutic benefits to this approach.
Although therapists may say they do not want to share reliable
improvement rates out of desire to protect the young person and not
destroy hope, it is sometimes not clear who is being protected.42
Young people with experience of service use as adolescents have
reported how they have felt a failure as they believed they were
the only ones not to improve with treatment.40 If more realistic
expectations are set with a focus on ongoing patient activation
and management of likely ongoing symptoms and difficulties, this
may actually prove beneficial in terms of outcomes for those
young people. It may also help children, young people and their
families make more informed choices about treatment and when
to stop. However, clearly this is a hypothesis awaiting further empir-
ical study.
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